A pilot study comparing 18F-PSMA-1007 to FDG PET in 21 patients reported similar primary tumour (intraprostatic) detection rates (100% vs 67%, respectively) but almost twice the detection of metastatic lesions by PSMA PET [27]. Here, FOLH1 is linked to neoplasm.